BVS - Bioventus Inc - Ordinary Shares - Class A
IEX Last Trade
10.05
0.170 1.692%
Share volume: 427,296
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
PREVIOUS CLOSE
CHG
CHG%
$9.88
0.17
1.72%
View ratios
| Fiscal Date | 2022-07-02 | 2022-10-01 | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-31 | 2024-03-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-21 | 2023-03-31 | 2023-05-16 | 2023-08-08 | 2023-11-07 | 2024-03-12 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 1.209 B | 1.398 B | 1.373 B | 887.404 M | 836.962 M | 811.104 M | 810.910 M | 794.238 M | |
| Current Assets | 277.157 M | 271.082 M | 272.575 M | 308.664 M | 260.638 M | 249.452 M | 267.999 M | 265.903 M | |
| Inventories | 69.078 M | 76.952 M | 85.408 M | 87.953 M | 96.276 M | 97.563 M | 91.333 M | 97.005 M | |
| Other Current Assets | 24.060 M | 27.563 M | 18.685 M | 17.192 M | 15.337 M | 12.163 M | 16.913 M | 18.184 M | |
| Short Term Investments | 24.060 M | 27.563 M | 18.685 M | 17.192 M | 15.337 M | 12.163 M | 16.913 M | 18.184 M | |
| Total Receivables | 143.018 M | 132.185 M | 136.645 M | 118.544 M | 119.636 M | 112.899 M | 122.789 M | 125.541 M | |
| Current Cash | 41.001 M | 34.359 M | 31.814 M | 47.102 M | 29.389 M | 26.827 M | 36.964 M | 25.173 M | |
| Total Non-current Assets | 931.619 M | 1.127 B | 1.100 B | 578.740 M | 576.324 M | 561.652 M | 542.911 M | 528.335 M | |
| Property Plant Equipment | 25.112 M | 26.643 M | 27.647 M | 36.556 M | 41.862 M | 39.704 M | 36.605 M | 34.532 M | |
| Other Assets | 96.828 M | 29.337 M | 19.944 M | 18.683 M | 21.777 M | 21.162 M | 16.494 M | 15.673 M | |
| Intangible Assets | 666.523 M | 1.056 B | 1.039 B | 516.039 M | 505.223 M | 493.324 M | 482.350 M | 470.668 M | |
| Goodwill | 143.156 M | 15.359 M | 13.759 M | 7.462 M | 7.462 M | 7.462 M | 7.462 M | 7.462 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.209 B | 1.398 B | 1.373 B | 887.404 M | 836.962 M | 811.104 M | 810.910 M | 794.238 M | |
| Total liabilities | 760.795 M | 1.055 B | 1.056 B | 698.893 M | 653.767 M | 633.575 M | 637.319 M | 622.962 M | |
| Total current liabilities | 198.873 M | 288.373 M | 304.017 M | 196.063 M | 179.104 M | 160.843 M | 175.497 M | 173.321 M | |
| Accounts Payable | 25.735 M | 19.075 M | 37.549 M | 32.828 M | 41.364 M | 17.637 M | 23.038 M | 19.099 M | |
| Other liabilities | 39.388 M | 178.101 M | 189.289 M | 46.363 M | 49.949 M | 48.772 M | 46.084 M | 46.761 M | |
| Current long term debt | 22.547 M | 31.302 M | 33.056 M | 41.320 M | 11.320 M | 19.584 M | 27.848 M | 35.811 M | |
| Long term debt | 351.433 M | 393.102 M | 385.010 M | 404.265 M | 374.568 M | 375.033 M | 366.998 M | 355.430 M | |
| Other liabilities | 39.388 M | 178.101 M | 189.289 M | 46.363 M | 49.949 M | 48.772 M | 46.084 M | 46.761 M | |
| Minority interest | 72.209 M | 35.749 M | 23.751 M | 51.851 M | 50.146 M | 48.927 M | 47.527 M | 46.156 M | |
| Total Shareholder equity | 447.981 M | 343.397 M | 316.581 M | 188.511 M | 183.195 M | 177.529 M | 173.591 M | 171.276 M | |
| Common stock | 61.475 M | 61.674 M | 61.922 M | 62.125 M | 62.551 M | 62.824 M | 63.090 M | 63.380 M | |
| Retained earnings | -25.131 M | -133.376 M | -165.306 M | -304.456 M | -308.137 M | -315.440 M | -321.536 M | -326.106 M |